Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Ergebnisse filtern

Condition

Audience

Topic

Type

January 13, 2023

Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention

Patients undergoing elective high-risk PCI are often in critical condition and not candidates for coronary artery bypass graft (CABG) surgery.

January 13, 2023

European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS)during high risk intervention, highlighting the following topics...

January 9, 2023

Best Practices for Optimizing Impella Use in High-Risk Patients

Prof. Dr. Nikos Werner introduces European best practices for optimizing Protected PCI with Impella heart pumps that were recently published in European Heart Journal Supplements.

December 2, 2022

Burzotta: Status Quo and Outlook for pMCS Strategies

Francesco Burzotta, MD, discusses the use of percutaneous mechanical circulatory support (pMCS) strategies in both high-risk PCI and cardiogenic shock.

October 27, 2022

Christophe Vandenbriele: Anticoagulation Challenges in Patiens Supported with Impella® Heart Pumps

Dr. Pal Soos interviews Prof. Dr. Christophe Vandenbriele, a cardiologist and intensivist from UZ Leuven (Belgium) and research fellow at Royal Brompton Hospital in London. Dr.

October 20, 2022

Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice

Vasileios Panoulas, MD, presents 3 patient case examples illustrating significant LV improvement with PCI supported with Impella heart pumps.

October 20, 2022

Clinical Trial Update with Chuck Simonton, MD

Chuck Simonton, MD, provides an update on clinical trials including PROTECT III, RESTORE EF, and PROTECT IV RCT.

October 11, 2022

EACTS 2022 on Demand - MCS for PCCS, Structural Heart Disease, and Advanced Cardiogenic Shock

Discover the recordings of our scientific session at EACTS 2022 about "Innovative Strategies for Superior Outcome in Cardiac Surgery Including pMCS Support in Therapy Pathway".

October 7, 2022

Dr. Junya Ako: J-PVAD Registry and Data Presented at TCT 2022 

Junya Ako, MD, discusses the J-PVAD registry and study data presented at TCT 2022 with Prof. Hermann Reichenspurner.

September 30, 2022

Dr. Navin Kapur: Cardiogenic Shock Working Group and SCAI Shock Stages–TCT 2022

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

September 30, 2022

Dr. Katherine Kunkel: Best Practices in Cardiogenic Shock–TCT 2022

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022. 

September 30, 2022

Dr. Navin Kapur: Lessons Learned in STEMI DTU™ Pilot Study–TCT 2022

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

September 29, 2022

Live from TCT – September 17, 2022

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day 1 of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.

September 29, 2022

Dr. Kate Kearney: Contemporary Techniques for Optimal Outcomes in High-risk PCI–TCT 2022

Kate Kearney, MD, presents a case and discusses contemporary techniques for optimal outcomes in high-risk PCI at TCT 2022. 

September 28, 2022

Live from TCT – September 18, 2022

This recap of highlights from day 2 of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller, and Taishi Hirai.

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891